Effects of Laparoscopic Sleeve Gastrectomy on Cardiac Structure and Function in Obese Patients With Heart Failure
- PMID: 40331381
- DOI: 10.3881/j.issn.1000-503X.16179
Effects of Laparoscopic Sleeve Gastrectomy on Cardiac Structure and Function in Obese Patients With Heart Failure
Abstract
Objective To investigate the effects of laparoscopic sleeve gastrectomy(LSG)on the cardiac structure and function in obese patients with heart failure(HF)and compare the efficacy of LSG across obese patients with different HF types.Methods This study included 33 obese patients with HF who underwent LSG.The clinical indicators were compared between before operation and 12 months after operation.Repeated measures analysis of variance was employed to evaluate the changes in echocardiographic parameters before operation and 3,6,and 12 months after operation.Patients were allocated into a HF with preserved ejection fraction group(n=17),a HF with mildly reduced ejection fraction group(n=5)and a HF with reduced ejection fraction(HFrEF)group(n=11)based on left ventricular ejection fraction(LVEF)before operation for subgroup analyses of the effects of LSG on the cardiac structure and function of obese patients with HF.The paired samples t-test was conducted to assess the degree of cardiac structural and functional alterations after LSG.Results The 33 patients included 69.7% males,with an average age of(35.3±9.9)years,and a body mass index(BMI)of(51.2±9.8)kg/m2.The median follow-up was 9.0(5.0,13.3)months.Compared with the preoperative values,the postoperative BMI(P=0.002),body surface area(BSA)(P=0.009),waist circumference(P=0.010),hip circumference(P=0.031),body fat content(P=0.007),and percentage of patients with cardiac function grades Ⅲ-IV(P<0.001)decreased.At the 12-month follow-up left atrial diameter(P=0.006),right atrial long-axis inner diameter(RAD1)(P<0.001),right atrial short-axis inner diameter(RAD2)(P<0.001),right ventricular inner diameter(P=0.002),interventricular septal thickness at end-diastolic(P=0.002),and left ventricular end-diastolic volumes(P=0.004)and left ventricular end-systolic volumes(P=0.003) all significantly reduced compared with preoperative values.Additionally,left ventricular fractional shortening and LVEF improved(both P<0.001).Subgroup analyses revealed that cardiac structural parameters significantly decreased in the HF with preserved ejection fraction,HF with mildly reduced ejection fraction,and HFrEF subgroups compared with preoperative values.Notably,the HFrEF group demonstrated the best performance in terms of left atrial diameter(P=0.003),left ventricular inner diameter at end-diastole(P=0.008),RAD1(P<0.001),RAD2(P=0.004),right ventricular inner diameter(P=0.019),left ventricular end-diastolic volume(P=0.004)and left ventricular end-systolic volume(P=0.001),cardiac output(P=0.006),tricuspid regurgitation velocity(P=0.002),and pulmonary artery systolic pressure(P=0.001) compared to preoperatively.Postoperative left ventricular fractional shortening(P<0.001,P=0.003,P<0.001)and LVEF(P<0.001,P=0.011,P=0.001)became higher in all the three subgroups than the preoperative values.Conclusions LSG decreased the body weight,BMI,and BSA,improved the cardiac function grade,reversed the enlargement of the left atrium and left ventricle,reduced the right atrium and right ventricle,and enhanced the left ventricular systolic function.It was effective across obese patients with different HF types.Particularly,LSG demonstrates the best performance in improving the structures of both atria and ventricles in obese patients with HFrEF.
目的 评估腹腔镜袖状胃切除术(LSG)对肥胖合并心力衰竭(HF)患者心脏结构及功能的影响,并比较其对肥胖合并不同HF类型患者心脏结构和功能影响的差异。方法 纳入33例接受LSG的肥胖合并HF患者,比较术前与术后12个月临床指标变化,并采用重复测量方差分析评估术前与术后3、6、12个月超声心动图参数变化。根据术前左心室射血分数(LVEF),将患者分为射血分数保留的心力衰竭组(n=17)、射血分数轻度降低的心力衰竭组(n=5)、射血分数降低的心力衰竭(HFrEF)组(n=11),亚组分析LSG对肥胖合并不同HF类型患者心脏结构和功能的影响,并采用配对样本t检验评估各亚组LSG术后心脏结构和功能改变程度。结果 纳入的33例患者男性占69.7%,术前平均年龄(35.3±9.9)岁,体重指数(BMI)为(51.2±9.8)kg/m2。中位随访时间为9.0(5.0,13.3)个月。与术前相比,术后BMI(P=0.002)、体表面积(P=0.009)、腰围(P=0.010)、臀围(P=0.031)、体脂含量(P=0.007)、纽约心脏病协会心功能分级 Ⅲ~IV级比例(P<0.001)均显著下降。术后随访12个月与术前相比,左心房内径(P=0.006)、右心房长轴内径(RAD1)(P<0.001)、右心房短轴内径(RAD2)(P<0.001)、右心室内径(P=0.002)、舒张末期室间隔厚度(P<0.001)、左心室舒张末期容积(P=0.004)和左心室收缩末期容积(P=0.003)均显著减小;而左心室缩短分数和LVEF均显著升高(P均<0.001)。亚组分析显示,射血分数保留的心力衰竭组、射血分数轻度降低的心力衰竭组和HFrEF组心脏结构参数较术前均显著改善。其中,HFrEF组在左心房直径(P=0.003)、左心室舒张末期内径(P=0.008)、RAD1(P<0.001)和RAD2(P=0.004)、右心室内径(P=0.019)、左心室舒张末期容积(P=0.004)、左心室收缩末期容积(P=0.001)、心输出量(P=0.006)、三尖瓣反流速度(P=0.002)、肺动脉收缩压(P=0.001)较术前均明显改善;3组术后左心室短轴缩短率(P<0.001,P=0.003,P<0.001)和LVEF(P<0.001,P=0.011,P=0.001)较术前均明显增高。结论 LSG减轻了肥胖合并HF患者的体重、BMI及体表面积,改善了心功能分级,不仅逆转了增大的左心房和左心室,还减小了右心房和右心室,提升了左心收缩功能。此外,LSG对肥胖合并不同HF类型患者均有效,尤其是对肥胖合并HFrEF型患者双心房和双心室结构改善最大。.
Keywords: cardiac function; cardiac structure; heart failure; laparoscopic sleeve gastrectomy; obesity.
Similar articles
-
Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.J Cardiol. 2024 Apr;83(4):250-257. doi: 10.1016/j.jjcc.2023.09.012. Epub 2023 Oct 5. J Cardiol. 2024. PMID: 37802201
-
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063. J Am Coll Cardiol. 2019. PMID: 31806129 Clinical Trial.
-
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4. ESC Heart Fail. 2021. PMID: 34085774 Free PMC article.
-
Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.J Cardiol. 2023 Jun;81(6):513-521. doi: 10.1016/j.jjcc.2023.01.010. Epub 2023 Feb 8. J Cardiol. 2023. PMID: 36758670
-
Effect of sodium-glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis.Cardiovasc Diabetol. 2021 Jan 25;20(1):25. doi: 10.1186/s12933-020-01209-y. Cardiovasc Diabetol. 2021. PMID: 33494751 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous